BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16018936)

  • 1. Glutathione S-transferase M1 gene but not insulin-like growth factor-2 gene or epidermal growth factor gene is associated with prostate cancer.
    Lai MT; Chen RH; Tsai FJ; Wan L; Chen WC
    Urol Oncol; 2005; 23(4):225-9. PubMed ID: 16018936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
    Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
    Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
    Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study.
    Quiñones LA; Irarrázabal CE; Rojas CR; Orellana CE; Acevedo C; Huidobro C; Varela NE; Cáceres DD
    Asian J Androl; 2006 May; 8(3):349-55. PubMed ID: 16625286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between glutathione S-transferase M1, T1 genotype and susceptibility to gastric cancer].
    Cai L; Yu S; Chen J
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Nov; 33(6):331-3. PubMed ID: 11864501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer.
    Nam RK; Zhang WW; Trachtenberg J; Jewett MA; Emami M; Vesprini D; Chu W; Ho M; Sweet J; Evans A; Toi A; Pollak M; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1429-37. PubMed ID: 14693733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis.
    Agalliu I; Lin DW; Salinas CA; Feng Z; Stanford JL
    Prostate; 2006 Oct; 66(14):1535-41. PubMed ID: 16921513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione S-transferase M1 gene null genotype and gastric cancer risk in Taiwan.
    Lai KC; Chen WC; Tsai FJ; Li SY; Chou MC; Jeng LB
    Hepatogastroenterology; 2005; 52(66):1916-9. PubMed ID: 16334806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population.
    Silig Y; Pinarbasi H; Günes S; Ayan S; Bagci H; Cetinkaya O
    Cancer Invest; 2006 Feb; 24(1):41-5. PubMed ID: 16466991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymorphism of metabolic gene and genetic susceptibility to prostate cancer].
    Guan TY; Li M; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1467-70. PubMed ID: 16318816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case control study on the impact of CYP450 MSPI and GST-M1 polymorphisms on the risk of lung cancer].
    Wang BG; Chen SD; Zhou WP; Zeng M; Li ZB; Cai XL; Wang DQ
    Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):93-7. PubMed ID: 15059326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
    Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
    J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men.
    Li M; Guan TY; Li Y; Na YQ
    Chin Med J (Engl); 2008 Feb; 121(4):305-8. PubMed ID: 18304461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
    Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
    Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
    Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
    Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
    Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the association between null genotypes of glutathione-S-transferases and Behcet's disease.
    Uzunoğlu S; Acar H; Okudan N; Gökbel H; Mevlitoğlu I; Sari F
    Arch Dermatol Res; 2006 Jan; 297(7):289-93. PubMed ID: 16283344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits.
    Wu SH; Tsai SM; Hou MF; Lin HS; Hou LA; Ma H; Lin JT; Yeh FL; Tsai LY
    Breast Cancer Res Treat; 2006 Nov; 100(1):93-8. PubMed ID: 16758119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of glutathione-S-transferase M1 and T1 and prostate cancer risk in a Tunisian population.
    Souiden Y; Mahdouani M; Chaieb K; Elkamel R; Mahdouani K
    Cancer Epidemiol; 2010 Oct; 34(5):598-603. PubMed ID: 20599479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.
    Johansson M; McKay JD; Wiklund F; Rinaldi S; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1644-50. PubMed ID: 19423539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.